IL6 and non-small cell lung carcinoma: One study demonstrated that the loss of TIMP3 expression might increase IL-6 production via the tumor necrosis factor α/nuclear factor κB pathway in patients with HPV-infected non-small cell lung cancer (Wu et al., 2012).